ArticleReproductive sciences (Thousand Oaks, Calif.)2022

Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients.

Xuefeng Lv et al.PubMed ↗Publisher ↗

No numbers read from the abstract.